Abstract:Introduction: The human endometrium undergoes cyclical changes of proliferation, differentiation and shedding. This cyclical process has been described as an inflammatory process. Menstrual abnormalities account for the morbidity of a large population of females in their reproductive age. Aberration in endometrial angiogenesis has been implicated in the mechanism of heavy menstrual bleeding (HMB). Although the precise mechanism for control the endometrial neoangionesis is not fully understood, vascular endothelial growth factor and other cytokines such as cyclooxygenases, prostaglandins, interleukin -8 and leukocytes have been implicated in both endometrial pathologies and angiogenesis dysregulation. In addition, heavy menstrual bleeding results from upregulation of the expression/synthesis of these local markers. Uterine fibroids are the most common benign tumor affecting the female reproductive tract. Heavy menstrual bleeding is the main presenting complaint of women with uterine fibroids. However, the mechanism by which uterine fibroids cause heavy menstrual bleeding has not been elicited yet. Therefore, the mechanism of action of different available treatments for this condition, including uterine artery embolisation is unclear. This thesis is based on the hypothesis that a) uterine fibroid changes the physiology of endometrium and we aimed to find out whether these markers work in a different way in heavy menstrual bleeding in those with uterine fibroids and those without., In addition I we wished to study whether uterine fibroid upregulate these local markers in heavy menstrual bleeding, whereas uterine artery emolisation down-regulates them. Methods: This thesis describes the use of endometrial samples, taken with a Pipelle sampler, collected from women with heavy menstrual bleeding both with uterine fibroids and also with normal uteri, to estimate the difference in the endometrial expression of the factors likely to be involved in the control of menstrual bleeding between the two groups. Results: The study found no differences between the expression of both either proteins or mRNA for the cytokines under investigation By using endometrium, myometrium and different types of fibroid tissue collected from women who had hysterectomies with the complaint of heavy menstrual bleeding, there was higher expression of VEGF, COX-2, PGE2 and IL8 proteins in fibroid than myometrial tissue. However, the level mRNA of expression for VEGF, COX-1, COX-2, IL8 and EP2 showed no differences between myometrial and fibroid tissue. In the same group, endometrial expression of these markers for women who had no hormonal therapy before operation compared with that for women who received gonadotropin releasing hormone agonists (GnRH), higher expression of VEGF mRNA in women who had GnRH agonists than those who had no any hormones. In fibroid tissue, GnRHdownregulated the expression of VEGF protein and other cytokines compared with those not on any hormonal therapy. In addition, the estimated serum levels of these factors, indicating a higher level of IL8 in the GnRH group than in the other group. Conclusion: It seems that theses markers play a role in HMB mechanism in both uterine fibroid and normal uteri group in same manner. In addition, they have a fundamental role in the growth of uterine fibroids as well.

A Meta Analysis of Serum Sex Hormone in Patients with Uterine Fibroids

Correlation Analysis of Estrogen Levels and Psychological Status Among Patients with Uterine Fibroids.

The Association Between Subclinical Atherosclerosis And Uterine Fibroids

HOMOCYSTEINE LEVELS IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS

Meta-Study of the Clinical Effect of Conservative Treatment in Uterine Fibroids

Effects of Chinese Herbal Medicine on Ovarian Functions in the Patients with Endometriosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study

A Study on Clinico-Pathological Profile of Breast Cancer Patients and Their Correlation With Uterine Fibroids Using Hormone Level and Receptor Status Assessment

Should Acupuncture Become a Complementary Therapy in the Treatment of Uterine Fibroid: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

The influence of uterine fibroids on adverse outcomes in pregnant women: a meta-analysis

Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021

A Multicenter Retrospective Cohort Study Assessing the Incidence of Anemia in Patients Associated With Uterine Fibroids

Analysis of medication data of women with uterine fibroids based on data mining technology

Aromatase Inhibitors for Uterine Fibroids.

The Effects and Costs of Laparoscopic Versus Abdominal Myomectomy in Patients with Uterine Fibroids: a Systematic Review and Meta-Analysis

The role of vascular endothelial growth factor and other cytokines in the aetiology of heavy menstrual bleeding in women with uterine fibroids

Curative Efficacy of Transabdominal Ultrasound-guided Lauromacrogol Combined with Radiofrequency Ablation in Treatment of Fibroid and Its Effects on Serum E2 and LH FSH Levels

Serum Sex Hormone Determination in Patients with hysteromyoma

Association of Body Size and Body Fat Distribution with Uterine Fibroids among Chinese Women

A preliminary investigation of pre - surgical anemia and iron deficiency of gynecological inpatients

Comparative Effectiveness and Safety of High-Intensity Focused Ultrasound for Uterine Fibroids: A Systematic Review and Meta-Analysis